Molecular epidemiology and transmission dynamics of Mycobacterium tuberculosis in Northwest Ethiopia: new phylogenetic lineages found in Northwest Ethiopia

BMC Infectious Diseases

Stefan Niemann¹  Arne C Rodloff³  Ulrich Sack²  Frank Emmrich²  Matthias Merker¹  Joerg Beer³  Belay Tessema² 

[1] Molecular Mycobacteriology, Research Center Borstel, Borstel, Germany;Translational Centre for Regenerative Medicine, University of Leipzig, Leipzig, Germany;Institute of Medical Microbiology and Epidemiology of Infectious Diseases, University Hospital of Leipzig, Leipzig, Germany

关键词: Transmission dynamics;    Molecular epidemiology;    Mycobacterium tuberculosis;   

Others  :  1170992
DOI  :  10.1186/1471-2334-13-131

 received in 2012-07-27, accepted in 2013-02-26,  发布年份 2013

【 摘 要 】

Background

Although Ethiopia ranks seventh among the world’s 22 high-burden tuberculosis (TB) countries, little is known about strain diversity and transmission. In this study, we present the first in-depth analysis of the population structure and transmission dynamics of Mycobacterium tuberculosis strains from Northwest Ethiopia.

Methods

In the present study, 244 M. tuberculosis isolates where analysed by mycobacterial interspersed repetitive unit - variable number tandem repeat 24-loci typing and spoligotyping methods to determine phylogenetic lineages and perform cluster analysis. Clusters of strains with identical genotyping patterns were considered as an indicator for the recent transmission.

Results

Of 244 isolates, 59.0% were classified into nine previously described lineages: Dehli/CAS (38.9%), Haarlem (8.6%), Ural (3.3%), LAM (3.3%), TUR (2.0%), X-type (1.2%), S-type (0.8%), Beijing (0.4%) and Uganda II (0.4%). Interestingly, 31.6% of the strains were grouped into four new lineages and were named as Ethiopia_3 (13.1%), Ethiopia_1 (7.8%), Ethiopia_H37Rv like (7.0%) and Ethiopia_2 (3.7%) lineages. The remaining 9.4% of the isolates could not be assigned to the known or new lineages. Overall, 45.1% of the isolates were grouped in clusters, indicating a high rate of recent transmission.

Conclusions

This study confirms a highly diverse M. tuberculosis population structure, the presence of new phylogenetic lineages and a predominance of the Dehli/CAS lineage in Northwest Ethiopia. The high rate of recent transmission indicates defects of the TB control program in Northwest Ethiopia. This emphasizes the importance of strengthening laboratory diagnosis of TB, intensified case finding and treatment of TB patients to interrupt the chain of transmission.

【 授权许可】

   
2013 Tessema et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]World Health Organization: Global Tuberculosis Control 2010. Geneva, Switzerland: WHO: WHO/HTM/TB/2010.7; 2010.
• [2]World Health Organization: Global tuberculosis control: epidemiology, strategy, financing. WHO report. Geneva, Switzerland: WHO: WHO/HTM/TB/2009.411; 2009.
• [3]Federal Ministry of Health: Guideline for program and clinical management of drug resistant tuberculosis. Ethiopia: FMOH: First ed. Addis Ababa; 2009.
• [4]World Health Organization: Anti-tuberculosis drug resistance in the world. Fourth Global Report. Geneva, Switzerland: WHO: WHO/HTM/TB/2008.394; 2008.
• [5]Tostmann AS, Kik V, Kalisvaart NA, Sebek MM, Verver S: Tuberculosis transmission by patients with smear-negative pulmonary tuberculosis in a large cohort in the Netherlands. Clin Infect Dis 2008, 47:1135-1142.
• [6]Dobler CC, Marks GB, Simpson SE, Crawford AB: Recurrence of tuberculosis at a Sydney chest clinic between 1994 and 2006: reactivation or reinfection? Med J Aust 2008, 188:153-155.
• [7]Paranjothy S, Eisenhut M, Lilley M, Bracebridge S, Abubakar I: Extensive transmission of Mycobacterium tuberculosis from 9 year old child with pulmonary tuberculosis and negative sputum smear. BMJ 2008, 337:a1184.
• [8]Allix C, Supply P, Fauville-Dufaux M: Utility of fast mycobacterial interspersed repetitive unit-variable number tandem repeat genotyping in clinical mycobacteriological analysis. Clin Infect Dis 2004, 39:783-789.
• [9]Mathema B, Kurepina NE, Bifani PJ, Kreiswirth BN: Molecular epidemiology of tuberculosis: current insights. Clin Microbiol Rev 2006, 19:658-685.
• [10]Allix-Beguec C, Fauville-Dufaux M, Stoffels K, Ommeslag D, Walravens K: Importance of identifying Mycobacterium bovis as a causative agent of human tuberculosis. Eur Respir J 2010, 35:692-694.
• [11]Agonafir M, Lemma E, Wolde-Meskel D, Goshu S, Santhanam A: Phenotypic and genotypic analysis of multidrug-resistant tuberculosis in Ethiopia. Int J Tuberc Lung Dis 2010, 14:1259-1265.
• [12]Hermans PW, Messadi F, Guebrexhaber H, van Soolingen D, de Haas PE: Analysis of the population structure of Mycobacterium tuberculosis in Ethiopia, Tunisia and the Netherlands: usefulness of DNA typing for global tuberculosis epidemiology. J Infect Dis 1995, 171:1504-1513.
• [13]Bruchfeld J, Aderaye G, Palme IB, Bjorvatn B, Ghebremichael S: Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates from Ethiopian pulmonary tuberculosis patients with and without human immunodeficiency virus infection. J Clin Microbiol 2002, 40:1636-1640.
• [14]Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rüsch-Gerdes S: Proposal for standardization of optimized mycobacterial interspersed repetitive unitvariable- number tandem repeat typing of Mycobacterium tuberculosis. J. Clin. Microbiol 2006, 44:4498-4510.
• [15]Tessema B, Beer J, Emmrich F, Sack U, Rodloff AC: Rate of recovery of Mycobacterium tuberculosis from frozen acid-fast-bacillus smear-positive sputum samples subjected to long term storage in Northwest Ethiopia. J Clin Microbiol 2011, 49:2557-2561.
• [16]Tessema B, Beer J, Emmrich F, Sack U, Rodloff AC: First line and second line anti-tuberculosis drugs resistance among tuberculosis patients in Northwest Ethiopia. Int J Tuberc Lung Dis 2012, 16:1-7.
• [17]Deutsches Institut für Normung (DIN): Medical microbiology - Diagnosis of tuberculosis - Part 3. Beuth Verlag, Berlin, Germany: DIN: Detection of mycobacteria by culture methods. DIN 58943–3; 1986.
• [18]Beer J, Küchler R, Rodloff AC: Investigations about the possibility for testing the susceptibility of mycobacteria with the MB/BacT culture system. J Lab Med 1997, 21:390-398.
• [19]Tortoli E, Mattei R, Savarino A, Bartolini L, Beer J: Comparison of Mycobacterium tuberculosis susceptibility testing performed with BACTEC 460 TB (Becton Dickinson) and MB/BacT (Organon Teknika) systems. Diagnostic Microbio Infec Dis 2000, 38:83-86.
• [20]Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D: Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997, 35:907-914.
• [21]Allix-Béguec C, Harmsen D, Weniger T, Supply P, Niemann S: Evaluation and user-strategy of MIRU-VNTRplus, a multifunctional database for on-line analysis of genotyping data and phylogenetic identification of Mycobacterium tuberculosis complex isolates. J Clin Microbiol 2008, 46:2692-2699.
• [22]Hunter PR, Gaston MA: Numerical index of the discriminatory ability of typing systems: an application of Simpson’s index of diversity. J Clin Microbiol 1988, 26:2465-2466.
• [23]Affolabi D, Anyo G, Faïhun F, Sanoussi N, Shamputa IC: First molecular epidemiological study of Mycobacterium tuberculosis in Benin. Int J Tuberc Lung Dis 2009, 13:317-322.
• [24]Shamputa IC, Jugheli L, Sadradze N, Willery E, Portaels F: Mixed infection and clonal representativeness of a single sputum sample in tuberculosis patients from a penitentiary hospital in Georgia. Respir Res 2006, 7:99. BioMed Central Full Text
• [25]Comas I, Homolka S, Niemann S, Gagneux S: Genotyping of genetically monomorphic bacteria: DNA sequencing in Mycobacterium tuberculosis highlights the limitations of current methodologies. PLoS One 2009, 4:e7815.
• [26]Sharaf Eldin GS, Fadl-Elmula I, Ali MS, Ali AB, Salih AL: Tuberculosis in Sudan: a study of Mycobacterium tuberculosis strain genotype and susceptibility to anti-tuberculosis drugs. BMC Infect Dis 2011, 11:219. BioMed Central Full Text
• [27]Vijaya-Bhanu N, van Soolingen D, van Embden JDA, Dar L, Pandey RM: Predominance of a novel Mycobacterium tuberculosis genotype in the Delhi region of India. Tuberculosis 2002, 82:105-112.
• [28]Gutierrez MC, Brisse S, Brosch R, Fabre M, Omaïs B: Ancient origin and gene mosaicism of the progenitor of Mycobacterium tuberculosis. PLoS Pathog 2005, 1:1-5.
• [29]Mardassi H, Namouchi A, Haltiti R, Zarrouk M, Mhenni B: Tuberculosis due to resistant Haarlem strain, Tunisia. Emerg Infect Dis 2005, 11:957-961.
• [30]Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J: The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med 1994, 330:1703-1709.
• [31]Barnes PF, Yang Z, Preston-Martin S, Pogoda JM, Jones BE: Patterns of tuberculosis transmission in Central Los Angeles. JAMA 1997, 278:1159-1163.
• [32]Niemann S, Rüsch-Gerdes S, Richter E, Thielen H, Heykes-Uden H: Stability of IS6110 restriction fragment length polymorphism patterns of Mycobacterium tuberculosis strains in actual chains of transmission. J Clin Microbiol 2000, 38:2563-2567.
• [33]Dorman SE, Chaisson RE: From magic bullets back to the Magic Mountain: the rise of extensively drug-resistant tuberculosis. Nature Med 2007, 13:295-298.
• [34]Pardini M, Niemann S, Varaine F, Iona E, Meacci F: Characteristics of drug-resistant tuberculosis in Abkhazia (Georgia), a high-prevalence area in Eastern Europe. Tuberculosis 2009, 89:317-324.
• [35]Victor TC, Streicher EM, Kewley C, Jordaan AM, van der Spuy GD: Spread of an emerging Mycobacterium tuberculosis drug-resistant strain in the western Cape of South Africa. Int J Tuberc Lung Dis 2007, 11:195-201.
• [36]Gagneux S, DeRiemer K, Van M, Kato-Maeda T, de Jong BC: Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2006, 103:2869-2873.